Levi & Korsinsky is commencing an investigation into the Board of
Directors of Hospira Inc. (“Hospira” or “the Company”) (NYSE:HSP) in
connection with possible breaches of fiduciary duty and other violations
of state law in connection with the sale of the Company to Pfizer.
for 2015/2/9 - UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Launches an Investigation of the Board of Directors of Hospira Inc. In Connection With the Fairness of the Sale of the Company to Pfizer -- HSP investment picks